**9. Conclusions**

There is a high incidence of endocrinological abnormalities in patients with thalassaemia. Thalassaemic patients have been shown to have an elevated frequency of endocrinopathies in several research centres. The role of regular follow-up to allow early detection and proper management of complications is vital. The care and quality of life of thalassaemic patients can be positively impacted by advancements in transfusion protocols and chelating therapy. Early recognition of endocrinopathies in patients with thalassaemia is crucial apart from the fact that life expectancy is increased, at the same time morbidity and mortality as a result of complications can be decreased with routine monitoring, appropriate interventions and follow-up in thalassaemia-endocrine join care clinics.
